We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
15/3/2016 09:20 | My takeover price 2000p Hope this helps | bad robot | |
15/3/2016 09:19 | Neil should phock off, an another freeloader advfn idiot. I am subsidizing the freeloaders, if you are not happy, too bad. Hope this helps | bad robot | |
15/3/2016 09:19 | 30k buy in | milliecusto | |
15/3/2016 09:15 | Tick tock tick tock | bad robot | |
15/3/2016 09:14 | Altom. There could be a very complex answer to your question so here's a simple guide. Various US analysts cover GWPH and they have a range of Price Targets from 725p to 925p. Such price targets are not necessarily accurate but they do show what's a reasonable medium-term guess. My guess would be if things go well with most of the seven placebo controlled trials still to report in 2016 and, if the market context stays as it is, we'll see a share price of maybe ten quid by the year end. | wengerb | |
15/3/2016 08:41 | Neilrr, I think I cannot moderate anyone with a blue name. I suggest you filter him | nodding | |
15/3/2016 08:36 | Well, chaps- I seem to have timed that one right! I think a quick whoop-whoop is in order. Whoop-whoop! That is all. | masingi | |
15/3/2016 08:32 | Nodding, can you please moderate the notorious ramper & thread destroyer, Bad Robot, before this thread goes to hell. I can't see that he's following your first rule - "MODERATION RULES: Price predictions to be supported by evidence/analysis." TIA. | neilrr | |
15/3/2016 08:24 | I bought a few of these on a tip from my youngest son. Can anybody tell me how they can be valued or is it all pretty much guess work ? | altom | |
15/3/2016 08:07 | Early shake,buying starting to kick in | milliecusto | |
15/3/2016 07:53 | Yes indeed longsight. I noticed that they were unwilling to say anything about the secondary endpoints, but this may be because they have not had much time to look at them. The secondary endpoints would be a factor for the FDA. Two LGS trial results next quarter, and I think the second Dravet trial result in H2 | nodding | |
15/3/2016 07:51 | Mugs tend to get wiped on morning to midday here. | bad robot | |
15/3/2016 07:48 | we gonna roll to 600p+ boom 1000p by friday MUG PUNTERS CAN WATCH AND LEARN. This is Ninja19 baby from 50p-60p. N19 gave heads up about this to his followers & fans at 100p In BR WE TRUST | bad robot | |
15/3/2016 07:43 | The big takeaway is that it appears we are looking at FDA submission based just on the one P3 trial - that will accelerate the approval process. The low PBO rate [13%] makes the data very robust as does the very lo P value. imo these results were as good as we cd hope for | longsight | |
15/3/2016 07:20 | Cheers Wenger. You can tell her from me that the sun is definitely up. There is nothing in the webcast that would surprise you, but hey, it's worth a listen anyway | nodding | |
14/3/2016 22:48 | Nodding. Still here in Vietnam. In a rather isolated location so the wi fi is too slow for the webcast but we're off to Saigon (yes, that's still the name mainly used in the South) on Wednesday. My wife's had to put up with my GWP fixation for nearly 17 years so, whilst very pleased with the news, it was right that she asked "this is not another false dawn is it?" I think it is fair to say that this is very likely the real deal. | wengerb | |
14/3/2016 21:10 | Easy £10 from here,should sail pass 52 wk high with this company changing news. | milliecusto | |
14/3/2016 21:03 | Also Roth Cap increased target share price to US$160: | longsight | |
14/3/2016 19:04 | Well year high was 708p and that's without today's news,any ideas on how high this can go,surely must be nudging £10 area | milliecusto | |
14/3/2016 18:52 | Justin looking good on US CNBC Power Lunch. Great promo. | randb01 | |
14/3/2016 17:02 | 600p tomorrow morning with or without the mugs. IN BR WE TRUST | bad robot | |
14/3/2016 16:39 | Let the news sink in tonight,strong finish into close,bodes well for tomorrow | milliecusto | |
14/3/2016 16:07 | I got those at 297 but I find very difficult to value now. clearly with a bid would make a live a lot easier to make decision but without what the value of the company can be? good luck to you all and let hope we keep smiling tomorrow | jovi1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions